Brawn Biotech
19.70
+0.03(+0.15%)
Market Cap₹5.91 Cr
PE Ratio31.40
IndustryHealthcare
Company Performance:
1D+0.15%
1M-10.45%
6M-0.71%
1Y-5.74%
5Y-20.72%
View Company Insightsright
More news about Brawn Biotech
13Aug 25
Brawn Biotech Reports Turnaround with Rs 23.60 Lacs Profit in Q1
Brawn Biotech Limited, a pharmaceutical company, has reported a significant turnaround in its Q1 financial performance. The company posted a profit of Rs 23.60 lacs, compared to losses in previous quarters. Revenue increased substantially to Rs 579.77 lacs, more than doubling from the previous quarter. The company's Earnings Per Share (EPS) improved to Rs 0.89. The statutory auditor conducted a limited review and found no issues with the financial results.
 no imag found
Brawn Biotech
19.70
+0.03
(+0.15%)
1 Year Returns:-5.74%
Industry Peers
Sun Pharmaceutical
1,731.80
(-0.03%)
Divis Laboratories
6,255.50
(-0.60%)
Torrent Pharmaceuticals
4,397.90
(+2.10%)
Dr Reddys Laboratories
1,300.20
(-0.55%)
Cipla
1,326.70
(+0.02%)
Lupin
2,250.20
(+0.39%)
Zydus Life Science
903.85
(-0.45%)
Mankind Pharma
2,054.70
(+0.40%)
Aurobindo Pharma
1,164.40
(+1.20%)
Alkem Laboratories
5,495.50
(+0.09%)